Vaxart
Price & Volume
Stats
See more52W Range | $0.52-$1.54 |
Market Cap | $164.8M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $13.9M |
Revenue Growth (YoY) | 371.4% |
Gross Profit (12 Mos) | -$80.9M |
Diluted EPS | -$0.45 |
News
See moreYahoo Finance • 3 months ago
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
Yahoo Finance • last year
Vaxart Provides Business Update and Reports Third Quarter 2023 Financial Results
Yahoo Finance • last year
Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers
Yahoo Finance • last year
Vaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2
About
CEO | Mr. Steven Lo |
CFO | Mr. Phillip Eric Lee |
Address | 170 Harbor Way, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |
